News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
8,390 Results
Type
Article (846)
Press Release (7560)
Section
Business (1824)
Career Advice (2)
Deals (247)
Drug Delivery (2)
Drug Development (1256)
FDA (164)
Job Trends (92)
News (3217)
Policy (244)
Tag
Academia (110)
Allergies (1)
Alliances (469)
ALS (16)
Alzheimer's disease (93)
Antibody-drug conjugate (ADC) (1)
Approvals (183)
Artificial intelligence (36)
ASCO (2)
Autoimmune disease (3)
Automation (2)
Bankruptcy (10)
Best Places to Work (78)
BioSpace Insights (3)
Breast cancer (3)
Cancer (46)
Cardiovascular disease (3)
Career advice (2)
Cell therapy (29)
Cervical cancer (1)
Clinical research (1106)
Collaboration (47)
Compensation (5)
COVID-19 (25)
C-suite (22)
Data (174)
Depression (9)
Diabetes (5)
Diagnostics (53)
Digital health (2)
Drug discovery (16)
Earnings (629)
Events (1182)
Executive appointments (12)
FDA (268)
Frontotemporal dementia (1)
Funding (43)
Gene editing (1)
Generative AI (3)
Gene therapy (8)
GLP-1 (8)
Government (20)
Healthcare (188)
Hematology (1)
Huntington's disease (3)
Indications (6)
Infectious disease (27)
Inflammatory bowel disease (1)
Intellectual property (9)
IPO (102)
Job creations (18)
Job search strategy (2)
JPM (1)
Layoffs (3)
Legal (39)
Lung cancer (5)
Machine learning (2)
Manufacturing (7)
MASH (2)
Medical device (275)
Medtech (280)
Mergers & acquisitions (170)
Metabolic disorders (15)
mRNA (1)
Multiple sclerosis (6)
Neurodegenerative disease (28)
Neuropsychiatric disorders (5)
Neuroscience (218)
Neurotech (1)
NextGen: Class of 2026 (106)
Non-profit (63)
Obesity (7)
Opinion (2)
Ovarian cancer (1)
Pain (38)
Pancreatic cancer (16)
Parkinson's disease (39)
Partnered (1)
Patents (30)
Patient recruitment (19)
People (533)
Phase 1 (404)
Phase 2 (516)
Phase 3 (299)
Pipeline (196)
Policy (2)
Postmarket research (18)
Preclinical (190)
Psychedelics (2)
Radiopharmaceuticals (5)
Rare diseases (17)
Real estate (20)
Regulatory (294)
Reports (2)
Research institute (100)
Rett syndrome (1)
Schizophrenia (11)
Series A (9)
Series B (5)
Special edition (1)
Spinal muscular atrophy (2)
Sponsored (1)
Startups (48)
Vaccines (7)
Venture capital (2)
Weight loss (2)
Date
Last 7 days (5)
Last 30 days (28)
Last 365 days (498)
2026 (327)
2025 (537)
2024 (539)
2023 (571)
2022 (823)
2021 (736)
2020 (494)
2019 (475)
2018 (287)
2017 (365)
2016 (420)
2015 (534)
2014 (398)
2013 (284)
2012 (267)
2011 (243)
2010 (221)
Location
Africa (2)
Asia (384)
Australia (101)
California (319)
Canada (52)
China (18)
Colorado (5)
Connecticut (4)
Delaware (1)
Europe (778)
Florida (26)
Georgia (7)
Idaho (3)
Illinois (11)
Indiana (31)
Japan (11)
Kentucky (1)
Louisiana (4)
Maine (4)
Maryland (13)
Massachusetts (113)
Michigan (2)
Minnesota (17)
Mississippi (1)
Missouri (1)
Nevada (6)
New Jersey (91)
New York (76)
North Carolina (8)
Northern California (136)
Ohio (4)
Pennsylvania (7)
Rhode Island (1)
South America (9)
South Carolina (1)
Southern California (127)
Tennessee (1)
Texas (123)
United States (861)
Utah (6)
Virginia (1)
Washington State (8)
Wisconsin (5)
8,390 Results for "neurelis".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Neurelis Provides Business Update Highlighting Transformational 2025 Results
January 13, 2026
·
9 min read
Press Releases
NEURELIS TO PRESENT ANALYSES OF IMMEDIATE-USE SEIZURE TREATMENT AT THE AMERICAN ACADEMY OF NEUROLOGY ANNUAL MEETING
April 17, 2026
·
8 min read
Press Releases
NEURELIS TO PRESENT CLINICAL DATA AT AMERICAN EPILEPSY SOCIETY ANNUAL MEETING
December 8, 2025
·
12 min read
Press Releases
NEURELIS TO PARTICIPATE IN SOFIE’S JOURNEY EPILEPSY AWARENESS DAY AND EDUCATION EXPO AT DISNEYLAND® RESORT
November 11, 2025
·
7 min read
Press Releases
Neurelis to Highlight Data from a Study of Diazepam Nasal Spray in Pediatric Patients at the Child Neurology Society Annual Meeting
October 9, 2025
·
8 min read
Press Releases
NEURELIS TO PRESENT STUDY OF NRL-1049, A RHO KINASE (ROCK) INHIBITOR WITH POTENTIAL TO TREAT SYMPTOMATIC CEREBRAL CAVERNOUS MALFORMATIONS (CCM), AT ANNUAL CCM MEETING
November 7, 2025
·
7 min read
Press Releases
NeurAxis to Host Second Quarter 2026 Results and Business Update Call on Tuesday, August 11, 2026
July 28, 2026
·
1 min read
Press Releases
NeuraClick Expands Scientific and Translational Leadership with Key Advisory Appointments
April 15, 2026
·
4 min read
Biotech Beach
NEURELIS ANNOUNCES PRESENTATIONS AT THE AMERICAN EPILEPSY SOCIETY ANNUAL MEETING
Neurelis, Inc., today announced that the company will present six poster presentations at the American Epilepsy Society (AES) Annual Meeting held in Orlando, Florida from December 1 – 5, 2023.
December 1, 2023
·
11 min read
Press Releases
Mission Therapeutics and NeuraLight Partner to Bring Precision Brain Function Biomarkers to a Global Parkinson’s Disease Clinical Trial
August 27, 2026
·
4 min read
1 of 839
Next
